These findings highlight a strong and statistically significant positive correlation between CA15-3 levels and BRCA1 gene expression in advanced stages of breast cancer (stage 3 and 4), even after accounting for potential confounding factors (Table 5). This evidence concerns the gene BRCA1 and breast carcinoma.